H, G., & J, C. (2025). GRB10 as a pan-cancer biomarker linking oncogenic signaling, immunosuppression, and immunotherapy resistance. Discover oncology, 16(1), 2269. https://doi.org/10.1007/s12672-025-04333-x
Chicago Style (17th ed.) CitationH, Guo, and Chen J. "GRB10 as a Pan-cancer Biomarker Linking Oncogenic Signaling, Immunosuppression, and Immunotherapy Resistance." Discover Oncology 16, no. 1 (2025): 2269. https://doi.org/10.1007/s12672-025-04333-x.
MLA (9th ed.) CitationH, Guo, and Chen J. "GRB10 as a Pan-cancer Biomarker Linking Oncogenic Signaling, Immunosuppression, and Immunotherapy Resistance." Discover Oncology, vol. 16, no. 1, 2025, p. 2269, https://doi.org/10.1007/s12672-025-04333-x.
Warning: These citations may not always be 100% accurate.